These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Sijssens KM, Rothova A, Van De Vijver DA, Stilma JS, De Boer JH. Am J Ophthalmol; 2007 Oct; 144(4):574-9. PubMed ID: 17706583 [Abstract] [Full Text] [Related]
8. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Yu EN, Paredes I, Foster CS. Ocul Immunol Inflamm; 2007 Feb; 15(1):11-7. PubMed ID: 17365801 [Abstract] [Full Text] [Related]
9. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations. Becker ML, van Haandel L, Gaedigk R, Lasky A, Hoeltzel M, Stobaugh J, Leeder JS. Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581 [Abstract] [Full Text] [Related]
10. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Schmeling H, Horneff G. Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187 [Abstract] [Full Text] [Related]
11. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A. J Rheumatol; 1995 Aug; 22(8):1574-6. PubMed ID: 7473486 [Abstract] [Full Text] [Related]
14. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ. Arthritis Rheum; 2009 Jan 15; 61(1):46-51. PubMed ID: 19116975 [Abstract] [Full Text] [Related]
15. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Bartoli M, Tarò M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, Magnani A, Gasparini C, Martini A, Ravelli A. Ann Rheum Dis; 2008 Mar 15; 67(3):370-4. PubMed ID: 17660217 [Abstract] [Full Text] [Related]
16. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Tappeiner C, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Eye (Lond); 2009 May 15; 23(5):1192-8. PubMed ID: 18551142 [Abstract] [Full Text] [Related]
18. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Am J Ophthalmol; 2011 Feb 15; 151(2):217-22. PubMed ID: 21145533 [Abstract] [Full Text] [Related]
19. Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course. Heinz C, Mingels A, Goebel C, Fuchsluger T, Heiligenhaus A. J Rheumatol; 2008 Jul 15; 35(7):1403-7. PubMed ID: 18484686 [Abstract] [Full Text] [Related]